Home/ Stocks/ OCS

Oculis Holding AG Ordinary shares

OCS XNAS

$12.68 +0.30 (+2.42%) ▲ 15-min delayed

Open

$12.95

High

$13.28

Low

$12.41

Volume

370.9K

Market Cap

$747.60M

About Oculis Holding AG Ordinary shares

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.

Employees: 60 Website →

Earnings & Analyst Ratings

Next Earnings: Thu, Nov 5, 2026

Calendar →

Related Market News

No specific coverage for OCS yet. Check out our latest market news or earnings calendar.

Get OCS Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Oculis Holding AG Ordinary shares.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.